CSPC Pharmaceutical Group Limited (CSPCY)

USD 2.34

(0.43%)

Annual Cash Flows

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow 4.17 Billion 7.62 Billion 4.63 Billion 6.73 Billion 3.78 Billion 3.95 Billion
Net Income 7.38 Billion 7.58 Billion 6.84 Billion 6.39 Billion 4.62 Billion 3.95 Billion
Depreciation & Amortization 1.11 Billion 1.04 Billion 865.47 Million 808.8 Million 691.59 Million 607.41 Million
Deferred income taxes - -1.53 Billion -1.42 Billion -1.94 Billion -900.43 Million -
Stock-based compensation 235.09 Million 160.72 Million 17.73 Million 9.12 Million 6.72 Million -
Change in working capital -3.03 Billion 798.12 Million -1.38 Billion 1.68 Billion -484.81 Million -363.28 Million
Other non-cash items -449.87 Million -428.95 Million -280.81 Million -203.68 Million -155.33 Million 470.36 Million
Investing Cash Flow 607.26 Million -6.79 Billion -637.32 Million -2.12 Billion -2.45 Billion -2.11 Billion
Investments in PPE -1.89 Billion -2.72 Billion -1.75 Billion -1.57 Billion -2.12 Billion -2 Billion
Acquisitions -115 Million -552.79 Million 40.21 Million -470.97 Million -406.03 Million -155.93 Million
Investment purchases -4.72 Billion -7.28 Billion -5.28 Billion -4.27 Billion -2.24 Billion -
Sales/Maturities of investments 6.74 Billion 3.41 Billion 5.38 Billion 4.14 Billion 2.59 Billion -
Other Investing Activities 167.56 Million 343.5 Million 975.39 Million 46.38 Million -270.55 Million 41.82 Million
Financing Cash Flow -2.3 Billion -1.9 Billion -2.19 Billion -1.47 Billion -1.54 Billion -157.32 Million
Debt repayment -27.84 Million -495.71 Million -99 Million -92.32 Million -70.58 Million -782.59 Million
Dividends payments -2.72 Billion -2.09 Billion -1.69 Billion -1.52 Billion -965.38 Million -782.87 Million
Common Stock Repurchased -200.35 Million -14.21 Million -263.51 Million - -100.7 Million -83.43 Million
Common Stock Issuance - 318.46 Million - - 1.22 Billion -
Other Financing Activities 834.05 Million 384.35 Million -143.33 Million 56.71 Million -1.63 Billion 1.49 Billion
Accounts receivables -1.97 Billion -566.54 Million -943.55 Million -445.45 Million -196.74 Million -519.66 Million
Accounts payables - 566.54 Million 943.55 Million 445.45 Million 196.74 Million -
Inventory -583.74 Million -42.75 Million -617.06 Million 601.43 Million 509.31 Million -614.03 Million
Other working capital -1.11 Billion 840.87 Million -770.85 Million 1.07 Billion -994.12 Million 770.4 Million
Cash at beginning of period 8 Billion 9.05 Billion 7.25 Billion 4.11 Billion 4.33 Billion 4.3 Billion
Cash at end of period 10.49 Billion 8 Billion 9.05 Billion 7.25 Billion 4.11 Billion 1.67 Billion
Capital Expenditure -1.89 Billion -2.72 Billion -1.75 Billion -1.57 Billion -2.12 Billion -2 Billion
Effect of forex changes on cash 4.89 Million 14.13 Million -2.44 Million 2.1 Million 1.45 Million -0.10
Net cash flow / Change in cash 2.48 Billion -1.05 Billion 1.8 Billion 3.14 Billion -217.37 Million -2.62 Billion
Free Cash Flow 2.28 Billion 4.9 Billion 2.87 Billion 5.16 Billion 1.66 Billion 1.94 Billion

Cash Flow Charts